Teleflex Incorporated ($TFX) Stock Forecast: Down 6.3% Today

What is Teleflex Incorporated?

Teleflex Incorporated (TFX) is a leading global provider of medical technologies. The stock TFX had a strong bearish movement today.

Why is Teleflex Incorporated going down?

TFX stock is down 6.3% on May 1, 2025 19:21

• Despite beating Q1 earnings and revenue estimates, the stock experienced a bearish movement, indicating that the market may have had higher expectations.
• The FDA clearance for expanded indications of one of Teleflex's medical devices may not have had the positive impact on the stock price as anticipated.
• The ongoing investigation by Pomerantz Law Firm into claims on behalf of investors could have raised concerns among shareholders, leading to the bearish market movement.
• Overall, the combination of high expectations, mixed reactions to regulatory news, and investor scrutiny may have contributed to the bearish trend in TFX stock today.

TFX Price Chart

TFX Technical Analysis

TFX News

Teleflex ( TFX ) Tops Q1 Earnings and Revenue Estimates

Teleflex (TFX) delivered earnings and revenue surprises of 1.04% and 0.22%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2459809/teleflex-tfx-tops-q1-earnings-and-revenue-estimates

Teleflex receives FDA 510 ( k ) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device - Teleflex ( NYSE:TFX )

WAYNE, Pa., April 30, 2025 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated TFX, a leading global provider of medical technologies, today announced U.S. Food and Drug Administration ( FDA ) 510 ( k ) clearance of an expansion to the Indications for Use of the QuikClot Control+™ Hemostatic Device to ...

https://www.benzinga.com/pressreleases/25/04/g45094876/teleflex-receives-fda-510-k-clearance-for-expanded-indications-of-the-quikclot-control-hemostatic-

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX - Teleflex ( NYSE:TFX )

NEW YORK, April 25, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Teleflex Incorporated ( "Teleflex" or the "Company" ) TFX. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

https://www.benzinga.com/pressreleases/25/04/g45023407/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-teleflex-incorpora

Trending Today

dogwifhat ($WIF) Crypto Forecast: Down 5.1% Today

Notcoin ($NOT) Crypto Forecast: Down 5.4% Today

Movement ($MOVE) Crypto Forecast: Down 22.5% Today

Sonic (prev. FTM) ($S) Crypto Forecast: Up 8.3% Today

MANTRA ($OM) Crypto Forecast: Down 7.3% Today

Litecoin ($LTC) Crypto Forecast: Up 5.0% Today

Ethena ($ENA) Crypto Forecast: Down 5.4% Today

Avalanche ($AVAX) Crypto Forecast: Up 5.4% Today

Cardano ($ADA) Crypto Forecast: Up 5.0% Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.2% Today

Teleflex Incorporated Price History

25.08.2024 - TFX Stock was up 0.7%

• Comparisons with EW indicate that TFX might be the better value option at the moment.
• Optimism about TFX's performance in the Interventional category and its potential in Asia has positively influenced investors.
• This optimism and potential value could be factors behind the bullish movement in TFX's stock today.

01.10.2024 - TFX Stock was up 5.3%

• TFX displayed a robust bullish trend today despite revising its 2024 revenue forecast downwards.
• Exceeding Q3 earnings projections and declaring a quarterly dividend likely bolstered investor confidence in the company's stock.
• The introduction of new vascular access products in Canada may have indicated growth prospects for TFX, playing a role in the positive market performance.
• The stock's upward movement seems influenced by favorable earnings results and strategic product introductions, potentially overshadowing concerns about the reduced revenue expectations.

28.01.2025 - TFX Stock was down 5.8%

• Surpassing Q4 earnings estimates and benefiting from a diversified product portfolio, TFX faced a bearish movement possibly due to a decline in gross margin.
• The announcement of the planned retirement of the Chief Financial Officer may have prompted concerns among investors regarding future financial strategies and leadership stability.
• While the quarterly dividend declaration was favorable, it may not have been enough to counter the impact of the CFO's retirement and the gross margin decline on investor sentiment.
• Overall, market participants seem to be taking a cautious approach towards TFX's future financial performance and strategic direction, influencing the stock price to move bearishly.

01.04.2025 - TFX Stock was down 6.3%

• Despite beating Q1 earnings and revenue estimates, the stock experienced a bearish movement, indicating that the market may have had higher expectations.
• The FDA clearance for expanded indications of one of Teleflex's medical devices may not have had the positive impact on the stock price as anticipated.
• The ongoing investigation by Pomerantz Law Firm into claims on behalf of investors could have raised concerns among shareholders, leading to the bearish market movement.
• Overall, the combination of high expectations, mixed reactions to regulatory news, and investor scrutiny may have contributed to the bearish trend in TFX stock today.

01.04.2025 - TFX Stock was down 5.1%

• The bearish movement in TFX stock could be due to investor concerns raised by the ongoing investigation by Pomerantz Law Firm regarding claims on behalf of investors.
• Despite the positive news of FDA clearance for expanded indications of their medical device, the uncertainty surrounding the investigation might have overshadowed the potential market impact.
• Investors may be cautious until more clarity is provided on the outcome of the investigation, leading to the downward movement in TFX stock price today.

18.01.2025 - TFX Stock was up 1.9%

• Teleflex's participation in the Raymond James & Associates 46th Annual Institutional Investors Conference is believed to have positively influenced investor sentiment, hinting at possible growth opportunities or favorable developments within the company.
• The upcoming conference presentation could serve as a platform for Teleflex to showcase its latest innovations, products, and strategic plans, possibly leading investors to expect strong performance and promising future prospects.
• Furthermore, the scheduled conference call to discuss the fourth quarter financial results and operational update may have fostered confidence among investors regarding the company's financial well-being and operational effectiveness, thereby contributing to the bullish movement in TFX stock.

31.09.2024 - TFX Stock was down 15.8%

• Despite surpassing Q3 earnings estimates, Teleflex saw a decline in its stock price.
• The company's announcement of a quarterly dividend is typically a show of confidence in its financial standing, yet it was not enough to counteract the bearish trend.
• The introduction of new vascular access devices in Canada may have been a positive move, but other factors appear to have influenced the stock's decline.
• Investor response to general market conditions or industry-specific challenges could be contributing to the downward trend in TFX stock, despite positive developments.

22.01.2024 - TFX Stock was down 5.3%

• Despite exceeding earnings and revenue expectations and providing positive guidance, the stock saw a decline.
• The decrease in Q4 profit, despite surpassing estimates, may have influenced market sentiment negatively.
• Concerns may arise regarding the company's dividend sustainability, as the quarterly dividend was set at 34 cents a share.
• The upcoming conference call scheduled for February 22 to review quarterly and annual financial results could offer additional insights into the company's performance and future prospects, potentially impacting the stock further.

03.05.2024 - TFX Stock was up 3.3%

• The successful commercialization of Teleflex's UroLift in Japan is boosting market share, highlighting strong potential for revenue growth.
• The expansion of this therapy for men with BPH (Benign Prostatic Hyperplasia) presents promising market opportunities for Teleflex, bolstering investor confidence and a bullish trend in the stock.
• Despite macroeconomic challenges like global economic uncertainties, Teleflex's strategic progress in the healthcare sector is outshining these concerns and fueling the bullish market movement of TFX.

18.06.2024 - TFX Stock was down 5.6%

• The downtrend in TFX stock could be linked to investor speculation about the upcoming second-quarter financial results conference call.
• There appears to be investor hesitancy or doubt regarding the operational update that will be provided during the call, resulting in a sell-off of TFX shares.
• Market participants may be responding to potential guidance or performance clues teased in the announcement, prompting some investors to proceed with caution and sell their Teleflex Incorporated holdings.
• Some investors may have been anticipating more positive developments or news from the conference call announcement, and the absence of such information could have contributed to the downward pressure on TFX stock.

27.01.2025 - TFX Stock was down 17.3%

• The downward trend in TFX stock today may be linked to profit-taking by investors following the stock's surpassing of Q4 earnings expectations. Positive news can sometimes trigger short-term selling pressure.
• Concerns among investors about potential changes in company leadership and future financial strategies may have arisen following the announcement of Thomas Powell's retirement as Chief Financial Officer.
• The market's uncertainty and volatility could have been influenced by Teleflex's announcement of its intention to split into two separate publicly traded entities, potentially impacting the stock's bearish movement.
• The amalgamation of these elements, combined with prevailing market conditions, likely played a role in the downward trajectory of TFX stock today.

01.07.2024 - TFX Stock was down 3.5%

• The bearish movement in TFX stock today could be attributed to profit-taking by investors after a series of positive news and earnings reports.
• Despite raising its profit forecast and surpassing earnings estimates, investors may have been expecting even better results, leading to a sell-off.
• The authorization for a significant share buyback program may have initially boosted the stock but was not enough to sustain the bullish momentum in the face of broader market pressures.
• Overall, the market reaction to TFX today seems to reflect a classic case of "buy the rumor, sell the news" behavior among investors.